Cabrini has received $6 million that will enable the establishment of a new Institute of Cancer at Cabrini Malvern, allowing researchers and clinicians to work together towards life-saving breakthroughs.
This funding is expected to allow for the number of patients on clinical trials to increase by more than 180 participants.
Cabrini Health Chief Executive Dr Michael Walsh said the funding commitment would support access to the best possible treatment options for present and future generations.
“Cabrini has always invested heavily in research and clinical trials to find better ways of treating cancer and improving the patient experience, with the Cabrini Institute having recently marked 20 years of education, health promotion and research,” Dr Walsh said.
“We welcome this investment from the Federal Government, which will enable us to undertake further research to help find new treatment methods so that our patients can live longer lives with less pain and discomfort.
“Cabrini’s new Gandel Wing, due to open in July this year, will provide expert, holistic care with people at the heart. It includes a new radiotherapy service, an expanded day oncology service and a new inpatient oncology ward, which means we will be able to offer an integrated cancer service with all treatments available onsite at Cabrini Malvern.”
The Federal Government funding commitment will provide:
This will enable researchers and clinicians to work together, giving them the best chance of developing breakthroughs and delivering better health outcomes for patients.